However, in the low-AD patient, a mismatch was observed between flortaucipir PET and histopathological tau burden whereby the hippocampus showed immature intracellular tau (AT8) on pathological examination but did not show elevated flortaucipir uptake on PET (Fig 5). Here, MAPT is linked to Alzheimer disease.